Patent classifications
A61K31/132
COMBINATION TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS
The inventions relate to compositions and methods for treating or preventing disorders of the central nervous system comprising administering to a patient, separately or in combination, an agent capable of normalizing copper levels and/or values and an agent capable of normalizing vitamin B.sub.5 levels, including in Alzheimer's disease patients.
COMBINATION TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS
The inventions relate to compositions and methods for treating or preventing disorders of the central nervous system comprising administering to a patient, separately or in combination, an agent capable of normalizing copper levels and/or values and an agent capable of normalizing vitamin B.sub.5 levels, including in Alzheimer's disease patients.
MUSCLE ENHANCER
A muscle enhancer containing a polyamine and a branched-chain amino acid as active ingredients. The polyamine may be one or more of putrescine, spermidine, and spermine, and may be derived from a yeast belonging to the genus Saccharomyces. The muscle enhancer may also comprise a crystalline polysaccharide. The muscle enhancer may be present in a food or a drink.
MUSCLE ENHANCER
A muscle enhancer containing a polyamine and a branched-chain amino acid as active ingredients. The polyamine may be one or more of putrescine, spermidine, and spermine, and may be derived from a yeast belonging to the genus Saccharomyces. The muscle enhancer may also comprise a crystalline polysaccharide. The muscle enhancer may be present in a food or a drink.
MUSCLE ENHANCER
A muscle enhancer containing a polyamine and a branched-chain amino acid as active ingredients. The polyamine may be one or more of putrescine, spermidine, and spermine, and may be derived from a yeast belonging to the genus Saccharomyces. The muscle enhancer may also comprise a crystalline polysaccharide. The muscle enhancer may be present in a food or a drink.
PUTRESCINE TOPICAL FORMULATIONS
The present invention describes complex topical aqueous compositions for the effective delivery of active ingredients such as putrescine and Vitamin C into the skin. These compositions may be used in a variety of cosmetic and therapeutic applications including for reducing or preventing skin's signs of aging, for promoting wound healing, for reducing or preventing the formation of hypertrophic scar tissue, for reducing or preventing skin irritation and/or inflammation.
PUTRESCINE TOPICAL FORMULATIONS
The present invention describes complex topical aqueous compositions for the effective delivery of active ingredients such as putrescine and Vitamin C into the skin. These compositions may be used in a variety of cosmetic and therapeutic applications including for reducing or preventing skin's signs of aging, for promoting wound healing, for reducing or preventing the formation of hypertrophic scar tissue, for reducing or preventing skin irritation and/or inflammation.
BODY FAT REDUCER
A body fat reducer containing a polyamine and a branched-chain amino acid as active ingredients. The polyamine may be one or more of putrescine, spermidine, and spermine, and may be derived from yeast. The body fat reducer may also comprise a crystalline polysaccharide. The body fat reducer may be present in a food or a drink.
BODY FAT REDUCER
A body fat reducer containing a polyamine and a branched-chain amino acid as active ingredients. The polyamine may be one or more of putrescine, spermidine, and spermine, and may be derived from yeast. The body fat reducer may also comprise a crystalline polysaccharide. The body fat reducer may be present in a food or a drink.
BODY FAT REDUCER
A body fat reducer containing a polyamine and a branched-chain amino acid as active ingredients. The polyamine may be one or more of putrescine, spermidine, and spermine, and may be derived from yeast. The body fat reducer may also comprise a crystalline polysaccharide. The body fat reducer may be present in a food or a drink.